L. Hansen Carl - Feb 22, 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Signature
/s/ Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Feb 22, 2022
Transactions value $
$151,538
Form type
4
Date filed
2/25/2022, 12:50 PM
Previous filing
Feb 3, 2022
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Options Exercise $152K +56.1K +25% $2.70 281K Feb 22, 2022 Direct
holding ABCL Common Shares 53.8M Feb 22, 2022 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share option (right to buy) Options Exercise $0 -56.1K -0.95% $0.00 5.86M Feb 22, 2022 Common Shares 56.1K $2.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person.
F2 The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.